메뉴 건너뛰기




Volumn 97, Issue 1, 2007, Pages 110-116

Assessment of HIV testing of urban injection drug users: Implications for expansion of HIV testing and prevention efforts

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ETHNICITY; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; RACE; SCREENING TEST; SECONDARY PREVENTION; SELF REPORT; SEX RATIO; SYRINGE EXCHANGE PROGRAM; UNITED STATES; URBAN POPULATION;

EID: 33846047496     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.2005.078105     Document Type: Article
Times cited : (30)

References (59)
  • 2
    • 0038662597 scopus 로고    scopus 로고
    • Advancing HIV prevention: New strategies for a changing epidemic-United States, 2003
    • Janssen RS, Onorato IM, Valdiserri RO, et al. Advancing HIV prevention: new strategies for a changing epidemic-United States, 2003. MMWR Morb Mortal Wkly Rep. 2004;52:329-332.
    • (2004) MMWR Morb Mortal Wkly Rep , vol.52 , pp. 329-332
    • Janssen, R.S.1    Onorato, I.M.2    Valdiserri, R.O.3
  • 3
    • 20444381790 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention, Atlanta, Ga: US Dept of Health and Human Services;
    • Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2003. Atlanta, Ga: US Dept of Health and Human Services; 2004.
    • (2004) HIV/AIDS Surveillance Report, 2003
  • 4
    • 0031934113 scopus 로고    scopus 로고
    • HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities
    • Kral AH, Bluthenthal RN, Booth RE, Watters JK. HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. Am J Public Health. 1998;88:108-113.
    • (1998) Am J Public Health , vol.88 , pp. 108-113
    • Kral, A.H.1    Bluthenthal, R.N.2    Booth, R.E.3    Watters, J.K.4
  • 5
    • 33846056050 scopus 로고    scopus 로고
    • Division of HIV/AIDS Prevention Centers for Disease Control and Prevention, Available at:, Accessed July 15
    • Division of HIV/AIDS Prevention Centers for Disease Control and Prevention. Advancing HIV Prevention: New Strategies for a Changing Epidemic. Available at: http://www.cdc.gov/hiv/partners/AHP-brochure.htm. Accessed July 15, 2005.
    • (2005) Advancing HIV Prevention: New Strategies for a Changing Epidemic
  • 6
    • 0033932171 scopus 로고    scopus 로고
    • HIV testing among the general US population and persons at increased risk: Information from national surveys, 1987-1996
    • Anderson JE, Carey JW, Taveras S. HIV testing among the general US population and persons at increased risk: information from national surveys, 1987-1996. Am J Public Health. 2000;90:1089-1095.
    • (2000) Am J Public Health , vol.90 , pp. 1089-1095
    • Anderson, J.E.1    Carey, J.W.2    Taveras, S.3
  • 7
    • 33846083806 scopus 로고    scopus 로고
    • HIV Testing Survey, 5. Atlanta, Ga: Centers for Disease Control and Prevention;
    • HIV Testing Survey. HIV/AIDS Special Surveillance Report 5. Atlanta, Ga: Centers for Disease Control and Prevention; 2002.
    • (2002) HIV/AIDS Special Surveillance Report
  • 8
    • 0036800553 scopus 로고    scopus 로고
    • HIV testing within at-risk populations in the United States and the reasons for seeking or avoiding HIV testing
    • Kellerman SE, Lehman JS, Lansky A, et al. HIV testing within at-risk populations in the United States and the reasons for seeking or avoiding HIV testing. J Acquir Immune Defic Syndr. 2002;31:202-210.
    • (2002) J Acquir Immune Defic Syndr , vol.31 , pp. 202-210
    • Kellerman, S.E.1    Lehman, J.S.2    Lansky, A.3
  • 9
    • 22344444456 scopus 로고    scopus 로고
    • Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: Implications for HIV prevention programs
    • Marks G, Crepaz N, Senterfritt W, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39:446-453.
    • (2005) J Acquir Immune Defic Syndr , vol.39 , pp. 446-453
    • Marks, G.1    Crepaz, N.2    Senterfritt, W.3    Janssen, R.S.4
  • 10
    • 13444267665 scopus 로고    scopus 로고
    • Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy
    • Sanders GD, Bayoumi AM, Sundaram V, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. New Engl J Med. 2005;352:570-585.
    • (2005) New Engl J Med , vol.352 , pp. 570-585
    • Sanders, G.D.1    Bayoumi, A.M.2    Sundaram, V.3
  • 11
    • 13444270732 scopus 로고    scopus 로고
    • Expanded screening for HIV in the United States-an analysis of cost-effectiveness
    • Paltiel AD, Weinstein MC, Rimmel AD, et al. Expanded screening for HIV in the United States-an analysis of cost-effectiveness. New Engl J Med. 2005;352:586-595.
    • (2005) New Engl J Med , vol.352 , pp. 586-595
    • Paltiel, A.D.1    Weinstein, M.C.2    Rimmel, A.D.3
  • 12
    • 13444256367 scopus 로고    scopus 로고
    • Routine screening for HIV infection-timely and cost-effective
    • Bozzette SA. Routine screening for HIV infection-timely and cost-effective. New Engl J Med. 2005;352:620-621.
    • (2005) New Engl J Med , vol.352 , pp. 620-621
    • Bozzette, S.A.1
  • 13
    • 21544461760 scopus 로고    scopus 로고
    • Screening for HIV: Recommendation statement
    • US Preventive Services Task Force
    • US Preventive Services Task Force. Screening for HIV: recommendation statement. Ann Intern Med. 2005;143:32-37.
    • (2005) Ann Intern Med , vol.143 , pp. 32-37
  • 14
    • 0036792621 scopus 로고    scopus 로고
    • Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities
    • Heimer R, Clair S, Grau LE, Bluthenthal RN, Marshall PA, Singer M. Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities. Addiction. 2002;97:1277-1287.
    • (2002) Addiction , vol.97 , pp. 1277-1287
    • Heimer, R.1    Clair, S.2    Grau, L.E.3    Bluthenthal, R.N.4    Marshall, P.A.5    Singer, M.6
  • 15
    • 4544310799 scopus 로고    scopus 로고
    • Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities
    • Bluthenthal RN, Malik MR, Grau LE, Singer M, Marshall PA, Heimer R. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction. 2004;99:1136-1146.
    • (2004) Addiction , vol.99 , pp. 1136-1146
    • Bluthenthal, R.N.1    Malik, M.R.2    Grau, L.E.3    Singer, M.4    Marshall, P.A.5    Heimer, R.6
  • 16
    • 0036955172 scopus 로고    scopus 로고
    • Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut 1990-2001
    • Heimer R, Clair S, Teng W, Grau LE, Khoshnood K, Singer M. Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut 1990-2001. J Urban Health. 2002;79:556-570.
    • (2002) J Urban Health , vol.79 , pp. 556-570
    • Heimer, R.1    Clair, S.2    Teng, W.3    Grau, L.E.4    Khoshnood, K.5    Singer, M.6
  • 17
    • 0142182394 scopus 로고    scopus 로고
    • Neighborhood differences in patterns of syringe access use, and discard among injection drug users: Implications for HIV outreach and prevention education
    • Buchanan D, Shaw S, Teng W, Hiser P, Singer M. Neighborhood differences in patterns of syringe access use, and discard among injection drug users: implications for HIV outreach and prevention education. J Urban Health. 2003;80:438-454.
    • (2003) J Urban Health , vol.80 , pp. 438-454
    • Buchanan, D.1    Shaw, S.2    Teng, W.3    Hiser, P.4    Singer, M.5
  • 18
    • 22744452200 scopus 로고    scopus 로고
    • Lessons from the field: From research to application in the fight against AIDS among injection drug users in three New England cities
    • Singer M, Stopka T, Shaw S, et al. Lessons from the field: from research to application in the fight against AIDS among injection drug users in three New England cities. Hum Organ. 2005;64:179-191.
    • (2005) Hum Organ , vol.64 , pp. 179-191
    • Singer, M.1    Stopka, T.2    Shaw, S.3
  • 19
    • 0004239560 scopus 로고
    • National Institute on Drug Abuse, Rockville, MD: National Institutes of Health, Dept of Health and Human Services;
    • National Institute on Drug Abuse. Risk Behavior Assessment. Rockville, MD: National Institutes of Health, Dept of Health and Human Services; 1991.
    • (1991) Risk Behavior Assessment
  • 20
    • 0025061894 scopus 로고
    • The limitations of the concept of needle sharing: The practice of frontloading
    • Grund JP, Kaplan CD, Adriaans NF, Blanken P, Huisman J. The limitations of the concept of needle sharing: the practice of frontloading. AIDS. 1990;4:819-821.
    • (1990) AIDS , vol.4 , pp. 819-821
    • Grund, J.P.1    Kaplan, C.D.2    Adriaans, N.F.3    Blanken, P.4    Huisman, J.5
  • 21
    • 17644424289 scopus 로고    scopus 로고
    • Drug sharing among heroin networks: Implications for HIV and hepatitis B and C prevention
    • Koester S, Glanz J, Baron A. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS Behav. 2005;9:27-39.
    • (2005) AIDS Behav , vol.9 , pp. 27-39
    • Koester, S.1    Glanz, J.2    Baron, A.3
  • 22
    • 0028915770 scopus 로고
    • HIV sero-prevalence in injection drug users
    • Watters JK, Bluthenthal RN, Kral AH. HIV sero-prevalence in injection drug users. JAMA. 1995;273:1178.
    • (1995) JAMA , vol.273 , pp. 1178
    • Watters, J.K.1    Bluthenthal, R.N.2    Kral, A.H.3
  • 23
    • 0034272442 scopus 로고    scopus 로고
    • Prevention of HIV infection in street-recruited injection drug users. The Collaborative Injection Drug User Study (CIDUS)
    • Monterroso ER, Hamburger ME, Vlahov D, et al. Prevention of HIV infection in street-recruited injection drug users. The Collaborative Injection Drug User Study (CIDUS). J Acquir Immune Defic Syndr. 2000;25:63-70.
    • (2000) J Acquir Immune Defic Syndr , vol.25 , pp. 63-70
    • Monterroso, E.R.1    Hamburger, M.E.2    Vlahov, D.3
  • 24
    • 4344633903 scopus 로고    scopus 로고
    • Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users
    • Friedman SR, Tempalski B, Cooper H, et al. Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. J Urban Health. 2004;81:377-400.
    • (2004) J Urban Health , vol.81 , pp. 377-400
    • Friedman, S.R.1    Tempalski, B.2    Cooper, H.3
  • 25
    • 0033819765 scopus 로고    scopus 로고
    • Factors associated with HIV testing and returning for test results in a sample of out-of-treatment drug users
    • Ziek K, Goldstein MF, Beardsley M, Deren S, Tortu S. Factors associated with HIV testing and returning for test results in a sample of out-of-treatment drug users. J Drug Issues. 2000;30:675-686.
    • (2000) J Drug Issues , vol.30 , pp. 675-686
    • Ziek, K.1    Goldstein, M.F.2    Beardsley, M.3    Deren, S.4    Tortu, S.5
  • 27
    • 0038217089 scopus 로고    scopus 로고
    • Trends in human immunodeficiency virus seroincidence among street-recruited injection drug users in San Francisco, 1987-1998
    • Kral AH, Lorvick J, Gee L, et al. Trends in human immunodeficiency virus seroincidence among street-recruited injection drug users in San Francisco, 1987-1998. Am J Epidermiol. 2003;157:915-922.
    • (2003) Am J Epidermiol , vol.157 , pp. 915-922
    • Kral, A.H.1    Lorvick, J.2    Gee, L.3
  • 28
    • 0034671622 scopus 로고    scopus 로고
    • Prevalence and incidence of HIV among out-of-treatment injecting drug users, Chicago 1994-1996
    • Quellet LJ, Thorpe LE, Huo D, et al. Prevalence and incidence of HIV among out-of-treatment injecting drug users, Chicago 1994-1996. J Acquir Immune Defic Syndr. 2000;25:443-450.
    • (2000) J Acquir Immune Defic Syndr , vol.25 , pp. 443-450
    • Quellet, L.J.1    Thorpe, L.E.2    Huo, D.3
  • 29
    • 0036784787 scopus 로고    scopus 로고
    • Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998
    • Nelson KE, Galai N, Safaeian M, Strathdee SA, Celentano DD, Vlahov D. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. Am J Epidemiol. 2002;156:641-653.
    • (2002) Am J Epidemiol , vol.156 , pp. 641-653
    • Nelson, K.E.1    Galai, N.2    Safaeian, M.3    Strathdee, S.A.4    Celentano, D.D.5    Vlahov, D.6
  • 30
    • 0037372517 scopus 로고    scopus 로고
    • Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City
    • Des Jarlais DC, Diaz T, Perlis T, et al. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol. 2003;157:467-471.
    • (2003) Am J Epidemiol , vol.157 , pp. 467-471
    • Des Jarlais, D.C.1    Diaz, T.2    Perlis, T.3
  • 31
    • 0028980674 scopus 로고
    • HIV incidence among New Haven needle exchange participants: Updated estimates from syringe tracking and testing data
    • Kaplan EH, Heimer R. HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10:175-176.
    • (1995) J Acquir Immune Defic Syndr Hum Retrovirol , vol.10 , pp. 175-176
    • Kaplan, E.H.1    Heimer, R.2
  • 32
    • 2942546614 scopus 로고    scopus 로고
    • Prevalence and incidence of HW, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons
    • Macalino GE, Vlahov D, Sanford-Colby S, et al. Prevalence and incidence of HW, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health. 2004;94:1218-1223.
    • (2004) Am J Public Health , vol.94 , pp. 1218-1223
    • Macalino, G.E.1    Vlahov, D.2    Sanford-Colby, S.3
  • 33
    • 0035313574 scopus 로고    scopus 로고
    • Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study
    • Seage GR III, Holte SE, Metzger D, et al. Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. Am J Epidemiol 2001;153:619-627.
    • (2001) Am J Epidemiol , vol.153 , pp. 619-627
    • Seage III, G.R.1    Holte, S.E.2    Metzger, D.3
  • 34
    • 23044510831 scopus 로고    scopus 로고
    • HIV incidence among injection drug users in New York City, 1990 to 2002: Use of serologic test algorithm to assess expansion of HIV prevention services
    • Des Jarlais DC, Perlis T, Arasteh K, et al. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health. 2005;95:1439-1444.
    • (2005) Am J Public Health , vol.95 , pp. 1439-1444
    • Des Jarlais, D.C.1    Perlis, T.2    Arasteh, K.3
  • 36
    • 5444253787 scopus 로고    scopus 로고
    • Correlates of HIV antibody testing among a sample of injection drug users: The role of social and contextual factors
    • Tobin KE, Tang AM, Gilbert SH, Latkin CA. Correlates of HIV antibody testing among a sample of injection drug users: the role of social and contextual factors. AIDS Behav. 2004;8:303-310.
    • (2004) AIDS Behav , vol.8 , pp. 303-310
    • Tobin, K.E.1    Tang, A.M.2    Gilbert, S.H.3    Latkin, C.A.4
  • 37
    • 0035237279 scopus 로고    scopus 로고
    • I don't know when it might pop up: Understanding repeat HIV testing and perceptions of HIV among drug users
    • Vernon KA, Mulia N, Downing M, Knight K, Riess T. "I don't know when it might pop up": understanding repeat HIV testing and perceptions of HIV among drug users. J Subst Abuse. 2001;13:215-227.
    • (2001) J Subst Abuse , vol.13 , pp. 215-227
    • Vernon, K.A.1    Mulia, N.2    Downing, M.3    Knight, K.4    Riess, T.5
  • 38
    • 0035670019 scopus 로고    scopus 로고
    • Motives for HIV testing among drug users: An analysis of gender differences
    • Riess TH, Kim C, Downing M. Motives for HIV testing among drug users: an analysis of gender differences. AIDS Educ Prev. 2001;13:509-523.
    • (2001) AIDS Educ Prev , vol.13 , pp. 509-523
    • Riess, T.H.1    Kim, C.2    Downing, M.3
  • 39
    • 0030817514 scopus 로고    scopus 로고
    • Gender differences and other factors associated with HIV testing in a national sample of active drug injectors
    • Davis WR, Deren S, Beardsley M, Wenston J, Tortu S. Gender differences and other factors associated with HIV testing in a national sample of active drug injectors. AIDS Educ Prev. 1997;9:342-358.
    • (1997) AIDS Educ Prev , vol.9 , pp. 342-358
    • Davis, W.R.1    Deren, S.2    Beardsley, M.3    Wenston, J.4    Tortu, S.5
  • 40
    • 0030449772 scopus 로고    scopus 로고
    • Utilization of HIV antibody testing by out-of-treatment drug users
    • Liebman J, Brooks D, Bonilla L, Kotranski L. Utilization of HIV antibody testing by out-of-treatment drug users. J Drug Issues. 1996;26:679-693.
    • (1996) J Drug Issues , vol.26 , pp. 679-693
    • Liebman, J.1    Brooks, D.2    Bonilla, L.3    Kotranski, L.4
  • 41
    • 24344453273 scopus 로고    scopus 로고
    • Acceptance of HIV antibody testing among inpatients and outpatients at a public health hospital: A study of rapid versus standard testing
    • Wurcel A, Zaman T, Zhen S, Stone D. Acceptance of HIV antibody testing among inpatients and outpatients at a public health hospital: a study of rapid versus standard testing. AIDS Patient Care STDS. 2005;19:499-505.
    • (2005) AIDS Patient Care STDS , vol.19 , pp. 499-505
    • Wurcel, A.1    Zaman, T.2    Zhen, S.3    Stone, D.4
  • 42
    • 14744305811 scopus 로고    scopus 로고
    • Choosing HIV counseling and testing strategies for outreach settings: A randomized trial
    • Spielberg F, Branson BM, Goldbaum GM, et al. Choosing HIV counseling and testing strategies for outreach settings: a randomized trial. J Acquir Immune Defic Syndr. 2005;38:348-355.
    • (2005) J Acquir Immune Defic Syndr , vol.38 , pp. 348-355
    • Spielberg, F.1    Branson, B.M.2    Goldbaum, G.M.3
  • 43
    • 32544454166 scopus 로고    scopus 로고
    • Supplemental testing for confirmation of reactive oral fluid rapid HIV antibody tests
    • Anonymous
    • Anonymous. Supplemental testing for confirmation of reactive oral fluid rapid HIV antibody tests. MMWR [dispatch]. 2005;54:1287-1288.
    • (2005) MMWR [dispatch] , vol.54 , pp. 1287-1288
  • 45
    • 0035330078 scopus 로고    scopus 로고
    • Injection-related risk behaviors in young urban and suburban injection drug users in Chicago (1997-1999)
    • Thorpe LE, Bailey SL, Huo D, Monterroso ER, Quellet LJ. Injection-related risk behaviors in young urban and suburban injection drug users in Chicago (1997-1999). J Acquir Immune Defic Syndr. 2001;27:71-78.
    • (2001) J Acquir Immune Defic Syndr , vol.27 , pp. 71-78
    • Thorpe, L.E.1    Bailey, S.L.2    Huo, D.3    Monterroso, E.R.4    Quellet, L.J.5
  • 46
    • 9144238059 scopus 로고    scopus 로고
    • Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001
    • Des Jarlais DC, Perlis T, Arasteh K, et al. "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001. J Acquir Immune Defic Syndr. 2004;35:158-166.
    • (2004) J Acquir Immune Defic Syndr , vol.35 , pp. 158-166
    • Des Jarlais, D.C.1    Perlis, T.2    Arasteh, K.3
  • 47
    • 33846110888 scopus 로고    scopus 로고
    • Syringe exchange, community coverage, declining AIDS rates
    • Paper presented at: June 13, Atlanta, Ga
    • Heimer R, Khoshnood K, Buchanan D, et al. Syringe exchange, community coverage, declining AIDS rates. Paper presented at: 2005 National HIV Prevention Conference; June 13, 2005; Atlanta, Ga.
    • (2005) 2005 National HIV Prevention Conference
    • Heimer, R.1    Khoshnood, K.2    Buchanan, D.3
  • 48
    • 0030978971 scopus 로고    scopus 로고
    • Needle exchange is not enough: Lessons from the Vancouver injecting drug use study
    • Strathdee SA, Patrick DM, Currie SL, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11:F59-F65.
    • (1997) AIDS , vol.11
    • Strathdee, S.A.1    Patrick, D.M.2    Currie, S.L.3
  • 49
    • 0038708362 scopus 로고    scopus 로고
    • Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic
    • Tyndall MW, Currie S, Spittal P, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 2003;17:887-893.
    • (2003) AIDS , vol.17 , pp. 887-893
    • Tyndall, M.W.1    Currie, S.2    Spittal, P.3
  • 50
    • 33846070151 scopus 로고    scopus 로고
    • HIV-infection Information Bulletin No. 1 [in Russian]. Russian Federal AIDS Center; 1994. In: Gardner KJ. HIV Testing and the Law in Russia; 1996. Available at: http://www.openweb.ru/aesop/eng/hiv-hr/hiv. html. Accessed May 25, 2005.
    • "HIV-infection" Information Bulletin No. 1 [in Russian]. Russian Federal AIDS Center; 1994. In: Gardner KJ. HIV Testing and the Law in Russia; 1996. Available at: http://www.openweb.ru/aesop/eng/hiv-hr/hiv. html. Accessed May 25, 2005.
  • 51
    • 1442315993 scopus 로고    scopus 로고
    • HIV transmission and HIV prevention associated with injecting drug use in the Russian Federation
    • Rhodes T, Sarang A, Bobrik A, Bobkov A, Platt L. HIV transmission and HIV prevention associated with injecting drug use in the Russian Federation. Int J Drug Policy. 2004;15:1-16.
    • (2004) Int J Drug Policy , vol.15 , pp. 1-16
    • Rhodes, T.1    Sarang, A.2    Bobrik, A.3    Bobkov, A.4    Platt, L.5
  • 52
    • 0004291545 scopus 로고    scopus 로고
    • National Institutes of Health Consensus Development Program, Bethesda, Md: National Institutes of Health;, Report 104
    • National Institutes of Health Consensus Development Program. Interventions to prevent HIV risk behaviors. Bethesda, Md: National Institutes of Health; 1997. Report 104.
    • (1997) Interventions to prevent HIV risk behaviors
  • 53
    • 0032125142 scopus 로고    scopus 로고
    • Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States
    • Holtgrave DR, Pinkerton SD, Jones TS, Lurie P, Vlahov D. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(suppl 1)5133-5138.
    • (1998) J Acquir Immune Defic Syndr Hum Retrovirol , vol.18 , Issue.SUPPL. 1 , pp. 5133-5138
    • Holtgrave, D.R.1    Pinkerton, S.D.2    Jones, T.S.3    Lurie, P.4    Vlahov, D.5
  • 54
    • 33846106824 scopus 로고    scopus 로고
    • Impact and cost-effectiveness of methadone maintenance programs for HIV and hepatitis C prevention
    • Weissing L, ed, Utrecht Netherlands: European Monitoring Centre for Drugs and Drug Addiction;
    • Pollack HA, Heimer R. Impact and cost-effectiveness of methadone maintenance programs for HIV and hepatitis C prevention. In: Weissing L, ed. Impact and Costs of Hepatitis C in Injecting Drug Users in the European Union. Utrecht Netherlands: European Monitoring Centre for Drugs and Drug Addiction; 2003.
    • (2003) Impact and Costs of Hepatitis C in Injecting Drug Users in the European Union
    • Pollack, H.A.1    Heimer, R.2
  • 55
    • 1442291565 scopus 로고    scopus 로고
    • Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world
    • Wood E, Montaner JS, Bangsberg DR, et al. Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world. AIDS. 2003;17:2419-2427.
    • (2003) AIDS , vol.17 , pp. 2419-2427
    • Wood, E.1    Montaner, J.S.2    Bangsberg, D.R.3
  • 56
    • 0142151386 scopus 로고    scopus 로고
    • Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users
    • Altice FL, Springer S, Buitrago M, Hunt DP, Friedland GH. Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users. J Urban Health, 2003;30:416-427.
    • (2003) J Urban Health , vol.30 , pp. 416-427
    • Altice, F.L.1    Springer, S.2    Buitrago, M.3    Hunt, D.P.4    Friedland, G.H.5
  • 57
    • 2942530602 scopus 로고    scopus 로고
    • Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: Implications for program replication
    • Altice FL, Mezger JA, Hodges J, et al. Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication. Clin Infect Dis. 2004;38(suppl 5):S376-S387.
    • (2004) Clin Infect Dis , vol.38 , Issue.SUPPL. 5
    • Altice, F.L.1    Mezger, J.A.2    Hodges, J.3
  • 58
    • 19544379027 scopus 로고    scopus 로고
    • Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodefiniciency virus infection
    • Vlahov D, Galai N, Safaeian M, et al. Effectiveness of highly active antiretroviral therapy among injection drug users with late-stage human immunodefiniciency virus infection. Am J Epidemiol. 2005;161:999-1012.
    • (2005) Am J Epidemiol , vol.161 , pp. 999-1012
    • Vlahov, D.1    Galai, N.2    Safaeian, M.3
  • 59
    • 4444227111 scopus 로고    scopus 로고
    • Mortality in HIV-seropositive versus seronegative persons in the era of highly active antiretroviral therapy: Implications for when to initiate therapy
    • Wang C, Vlahov D, Galai N, et al. Mortality in HIV-seropositive versus seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy. J Infect Dis. 2004;190:1046-1054.
    • (2004) J Infect Dis , vol.190 , pp. 1046-1054
    • Wang, C.1    Vlahov, D.2    Galai, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.